Bath & Body Works (NYSE:BBWI) Issues FY 2025 Earnings Guidance

Bath & Body Works (NYSE:BBWI) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 3.350-3.600 for the period, compared to the consensus estimate of 3.460. The company issued revenue guidance of -, compared to the consensus revenue estimate of $7.5 billion. Bath & Body Works also updated its Q3 2025 guidance to 0.370-0.45 EPS.

Analyst Upgrades and Downgrades

Several research firms have issued reports on BBWI. Citigroup dropped their price objective on Bath & Body Works from $42.00 to $40.00 and set a “buy” rating on the stock in a report on Tuesday, August 19th. Wells Fargo & Company lifted their price objective on Bath & Body Works from $40.00 to $44.00 and gave the stock an “overweight” rating in a report on Wednesday, May 14th. Morgan Stanley dropped their price objective on Bath & Body Works from $49.00 to $43.00 and set an “overweight” rating on the stock in a report on Tuesday, May 6th. Wall Street Zen downgraded Bath & Body Works from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Finally, JPMorgan Chase & Co. boosted their price target on Bath & Body Works from $40.00 to $46.00 and gave the company an “overweight” rating in a report on Monday, July 28th. Fourteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, Bath & Body Works presently has a consensus rating of “Moderate Buy” and an average target price of $42.53.

Bath & Body Works Price Performance

Shares of NYSE BBWI opened at $31.64 on Thursday. Bath & Body Works has a 1-year low of $24.94 and a 1-year high of $41.87. The business’s fifty day moving average price is $30.58 and its two-hundred day moving average price is $30.90. The firm has a market capitalization of $6.70 billion, a PE ratio of 8.44, a P/E/G ratio of 1.05 and a beta of 1.54.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.02. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%.The firm had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.42 billion. During the same period last year, the company earned $0.38 earnings per share. The firm’s revenue for the quarter was up 2.9% on a year-over-year basis. Equities research analysts expect that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be given a $0.20 dividend. The ex-dividend date of this dividend is Friday, August 22nd. This represents a $0.80 annualized dividend and a yield of 2.5%. Bath & Body Works’s dividend payout ratio (DPR) is currently 21.33%.

Institutional Investors Weigh In On Bath & Body Works

Large investors have recently added to or reduced their stakes in the stock. Geneos Wealth Management Inc. increased its position in Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after buying an additional 801 shares during the period. EverSource Wealth Advisors LLC boosted its position in Bath & Body Works by 155.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 4,456 shares of the company’s stock worth $134,000 after acquiring an additional 2,714 shares during the period. State of Wyoming boosted its position in Bath & Body Works by 6.2% during the 2nd quarter. State of Wyoming now owns 11,294 shares of the company’s stock worth $338,000 after acquiring an additional 661 shares during the period. Oxford Asset Management LLP acquired a new position in Bath & Body Works during the 2nd quarter worth $340,000. Finally, Gamco Investors INC. ET AL acquired a new position in Bath & Body Works during the 2nd quarter worth $445,000. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.